POINT
PNTPOINT Biopharma Price (PNT)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
96,034,506
(30.0385)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
POINT Biopharma Global Inc.Currency: USD
| YEAR | 2019 | 2020 | 2021 | 2022 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
0.00
+0% |
0.00
+0% |
226,579,563.00
+0% |
|||||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
0.00
+0% |
0.00
+0% |
0.00
+0% |
226,579,563.00
+0% |
|||||||||||||||
| Gross Profit Ratio | (0.00%) | (0.00%) | (0.00%) | (1.00%) | |||||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 1,160.00 | 9,142,156.00 | 33,505,392.00 | 82,050,392.00 | |||||||||||||||
| General and Administrative | 27,720.00 | 3,972,649.00 | 12,006,438.00 | 19,006,876.00 | |||||||||||||||
| Selling, General & Admin... | 34,956.00 | 3,972,649.00 | 12,006,438.00 | 19,006,876.00 | |||||||||||||||
| Selling & Marketing Exp... | 7,236.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Depreciation and Amortiz... | 171,860.00 | 206,297.00 | 11,840.00 | 1,800,556.00 | |||||||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Total Operating Expenses | 36,896.00 | 13,114,805.00 | 45,511,830.00 | 101,057,268.00 | |||||||||||||||
| Cost and Exponses | 36,896.00 | 13,114,805.00 | 45,511,830.00 | 101,057,268.00 | |||||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-36,116.00
+0% |
-13,114,805.00
+36,213% |
-45,511,830.00
+247% |
125,522,295.00
-376% |
|||||||||||||||
| Operating Income Ratio | (0.00%) | (0.00%) | (0.00%) | (0.55%) | |||||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 5,354.00 | 11,840.00 | 4,469,320.00 | |||||||||||||||
| Interest Expenses | 0.00 | 5,354.00 | 11,840.00 | 0.00 | |||||||||||||||
| Total Other Income/Exp... | -780.00 | -170,316.00 | -84,993.00 | 4,063,793.00 | |||||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -780.00 | -13,114,805.00 | -45,511,830.00 | 127,322,851.00 | |||||||||||||||
| EBITDA ratio | (0.00%) | (0.00%) | (0.00%) | (0.56%) | |||||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -36,896.00 | -13,285,121.00 | -45,596,823.00 | 129,586,088.00 | |||||||||||||||
| Income Before Tax Ratio | (0.00%) | (0.00%) | (0.00%) | (0.57%) | |||||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -780.00 | 87,882.00 | 305,658.00 | 31,292,875.00 | |||||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -36,896.00
+0% |
-13,373,003.00
+36,145% |
-45,902,481.00
+243% |
98,293,213.00
-314% |
|||||||||||||||
| Net Income Ratio | (0.00%) | (0.00%) | (0.00%) | (0.43%) | |||||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.00 | -0.34 | -0.62 | 1.04 | |||||||||||||||
| Diluted EPS | 0.00 | -0.34 | -0.62 | 1.02 | |||||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 0.00 | 38,875,643.00 | 73,850,822.00 | 94,601,214.00 | |||||||||||||||
| Diluted Share Outstanding | 0.00 | 38,875,643.00 | 73,850,822.00 | 96,034,506.00 | |||||||||||||||